Conclusion: Alprostadil group and candesartan group on early diabetic nephropathy treatment is effective, but the two combined with more significant effect.
Objective: The aim of this study was to study the impacts and the mechanisms of low-dose rapamycin combined with valsartan on the renal functions of diabetic nephropathy (DN) rats. Methods: Fifty SD rats were randomly divided into the normal control group (group A, n Z 10) and the DN model group (n Z 40), the DN model group was intraperitoneally injected streptozocin (STZ) for the modeling, which were then equally divided into the DN group (group B), the rapamycin group (group C, orally administrated rapamycin 1 mg/kg/d), the valsartan group (group D, orally administrated valsartan 30 mg/kg/d) and the combined therapy group (group E, orally administrated rapamycin 1 mg/kg/d + valsartan 30 mg/kg/d). Group A and group B were orally administrated the same amount of 0.5% carboxymethylcellulose. After 8-week treatment, the rats of each group were killed for the renal functional and pathological detection, as well as the expression detection of nephrin and podocin of kidney tissues. Results: Compared with group A, the renal functions of the DN model groups were all decreased, and the pathological changes were significant. Meanwhile, the expressions of nephrin/podocin were reduced (P < 0.05); among which group B exhibited the most serious changes, while the situations of group E were improved after the combined treatment, the expressions of nephrin/podocin were increased.
Conclusion: Low-dose rapamycin and valsartan could enhance the expressions of nephrin and podocin, reduce kidney damages, thus achieving the protective effects towards the kidneys, and the effects of the combined therapy were superior to those of monotherapy. Objective: The aim of this research was to analyze the correlation between the sharing Molecule of endocytosis and autophagy Rab7 and matrix metalloproteinase-2 (MMP-2) of paraffin sections of renal biopsy of patients with diabetic nephropathy, and then lay foundation for further study of the pathogenesis of diabetic nephropathy, thereby expected to bring new prospect for clinical treatment. Methods: The renal biopsy specimens were obtained from 20 patients with diabetic nephropathy, and the tissues were fixed in 10% neutral bufferedformalin, paraffin-embedded, serial 3-um sections were prepared. Immunohistochemistry staining (IHC) and periodic acid-schiff staining (PAS) were combined to detecte the expression of Rab7 and MMP-2. The pictures were obtained by special digital camera. And the average integral optical density was calculated by Image Pro Plus 6.0 (IPP). Besides, the degree of tubulointerstitial fibrosis was observed by standard light microscope and the thickness of the tubular basement membrane was measured by the software of IPP 6.0. Then the numerical value of the average integral optical density of Rab7 and MMP-2 was used to conduct the linear correlation analysis by SPSS 21.0. Results: Every section was observed under the standard light microscope, the specific masculine brown-yellow color reaction was seen in the cytoplasm of some human renal proximal tubular cells. Besides, in some areas, tubular atrophy and basement membrane thickening and occurrence of fibrosis can be seen clearly because of the use of PAS staining. The correlation coefficient of Pearson (r) is 0.516. And the value of P is 0.004 (P < 0.05). Conclusion: Our research revealed that in patients with diabetic nephropathy, there is association between Rab7 and MMP-2, that is to say, endocytosis and autophagy, connected to enzymes (herein referred to as MMP-2), involved in extracellular matrix (ECM) degradation, interact and participate in the progress of the change of tubular basement membrane thickness and tubulointerstitial fibrosis in diabetic nephropathy with proteinuria as the clinical feature.
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